Atorvastatin Calcium Hydrate/Torcetrapib

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAtorvastatin Calcium Hydrate/Torcetrapib
Drug Alias NameAtorvastatin/TorcetrapibTorcetrapib/Atorvastatin Calcium HydrateTorcetrapib/atorvastatin
ClassificationSmall molecules
Mechanisms of ActionHMG-CoA reductase inhibitorsHDL-cholesterol stimulantsCholesteryl ester transfer protein inhibitors
TargetsHDL-cholesterolCholesteryl ester transfer proteinHMG-CoA reductase
Therapy Area/IndicationsHypertriglyceridemiaHypercholesterolemiaHyperlipidemias +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[18] 
CombinationsYes TorcetrapibAtorvastatin Calcium Hydrate
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGodecke GmbhPfizer LtdPfizer Inc +[4] 
Active IndicationsN/A
Inactive IndicationsHypertriglyceridemiaHypercholesterolemiaHyperlipidemias +[10] 

Other Information

ATC CodeN/A
Related LinksN/A